VMP 375194009

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Mirtazapine 15mg orodispersible tablets
BNF code 0403040X0AAALAL
Virtual Therapeutic Moiety Mirtazapine
Date identifier became valid 19 Aug 2005
Previous product identifier 5627811000001105
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Mirtazapine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 15.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletdispersible.oral
Dose Form
Formulation Orodispersible tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Mirtazapine 15mg orodispersible tablets (A A H Pharmaceuticals Ltd)
Mirtazapine 15mg orodispersible tablets (Accord Healthcare Ltd)
Mirtazapine 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd)
Mirtazapine 15mg orodispersible tablets (Almus Pharmaceuticals Ltd)
Mirtazapine 15mg orodispersible tablets (DE Pharmaceuticals)
Mirtazapine 15mg orodispersible tablets (Medihealth (Northern) Ltd)
Mirtazapine 15mg orodispersible tablets (Medreich Plc)
Mirtazapine 15mg orodispersible tablets (Milpharm Ltd)
Mirtazapine 15mg orodispersible tablets (Phoenix Healthcare Distribution Ltd)
Mirtazapine 15mg orodispersible tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Mirtazapine 15mg orodispersible tablets 30 tablet
Mirtazapine 15mg orodispersible tablets 6 tablet

dm+d data retrieved from TRUD: release NHSBSA_9.3.0_20220926000001, imported on 26th September 2022 at 04:57:40.